microdosing semaglutide for perimenopause GLP-1s for Menopause-Related Weight Gain 💉 Using HRT and weight

As with any pharmaceutical intervention, there are specific criteria and considerations for its use: Suitable candidates for cagrilintide treatment typically include: Adults with a Body Mass Index (BMI) of 30 or greater (classified as obese) Adults with a BMI of 27 or greater (overweight) with at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or dyslipidemia Individuals who have not achieved sufficient weight loss through diet and exercise alone Patients without contraindications to amylin analogs or GLP-1 receptor agonists (when used in combination) It's crucial to note that cagrilintide is not recommended for certain groups, including: Pregnant or breastfeeding women Individuals with a personal or family history of medullary thyroid carcinoma Patients with Multiple Endocrine Neoplasia syndrome type 2 Those with a history of pancreatitis or severe gastrointestinal disorders Before initiating treatment with cagrilintide, a comprehensive medical evaluation is necessary

This can help level set the playing field so it can be a little more achievable to engage in healthier behaviors around food, says Aaron S

This therapy is commonly used to support metabolic efficiency and overall vitality

Adequate absorption of some minerals is also a bit tricky